Discontinued — last reported Q4 '17
Indefinite-Lived Research and Development Assets
LPL Financial Holdings Indefinite-Lived Research and Development Assets decreased by 90.7% to $2.06M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Indefinite-Lived Research and Development Assets shows a downward trend with a -58.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assetsHistorical Data
| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $28.86M | $19.29M | $22.16M | $2.06M |
| QoQ Change | — | -33.1% | +14.9% | -90.7% |
| YoY Change | — | -33.1% | +14.9% | -90.7% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is LPL Financial Holdings's indefinite-lived research and development assets?
- LPL Financial Holdings (LPLA) reported indefinite-lived research and development assets of $2.06M in Q4 2025.
- What is the long-term trend for LPL Financial Holdings's indefinite-lived research and development assets?
- Over 3 years (2022 to 2025), LPL Financial Holdings's indefinite-lived research and development assets has grown at a -58.5% compound annual growth rate (CAGR), from $28.86M to $2.06M.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.